drugset / Trial / NCT01101529

Treatment of Chemotherapy-induced Nausea and Vomiting

NCT01101529

Phase 2 Completed 90 enrolled Uppsala University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Delayed nausea is a common problem after high dose chemotherapy for bone marrow transplantation. This study wants to compare standard prophylactic anti-emetic therapy with the same treatment plus the drug aprepitant (Emend). The hypothesis is that addition of Emend will reduce nausea and vomiting.

Timeline

Start
2010-05
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified 80 mg Oral

Indications

No indication recorded.